Pharmaceutical Executive March 6, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive interview, Daniel Ayala, Chief Security and Trust Officer, Dotmatics, dives into the greatest threats to the integrity of data in R&D and threats presented by hackers.

In a world rife with optimism about the good that AI can do, what threat is presented to pharma by bad actors, like hackers, but for their own nefarious purposes?

AI brings a lot of potential benefits, AI accelerates a lot of thinking, it can contemplate a lot of data, it can, it can help us, you know, filter out things. And I’m not going to go into the cautions of AI in the drug discovery process. But I’ll talk about the way AI. The way we use AI or...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Big Data, Biotechnology, Cybersecurity, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article